PLEKHA1 and neoplasm: Together, these results confirm that the oncogenic PLEKHA1-TACC2 fusion protein activates the EphA2/AKT/MMP2 signaling pathway through stabilizing EphA2 expression and plays a vital role in tumor VM formation.